A market place in Ghana’s capital Accra. Developing countries like Ghana risk being left behind in the race to secure COVID-19 vaccines.
Christian Thompson/Anadolu Agency via Getty Images
A waiver on some intellectual property rules at the WTO for COVID-19 vaccines would ensure more equitable access, but wouldn't solve all the problems facing developing countries.
The TRIPS waiver enables WTO member states to manufacture and distribute COVID-19 drugs and medical supplies that would normally be protected by patents.
The TRIPS waiver makes COVID-19 treatments more accessible globally by enabling manufacture and distribution of COVID-19 drugs and medical supplies that would normally be protected by patents.
There's a risk Australia won't get access to everything it will need need. It can take are simple stepsto make sure patents don't get in the way.
Only by importing and manufacturing generic drugs can developing nations afford to meet their people’s health care needs.
Mohamed Abd El Ghany/Reuters
After nearly two decades of legal battles and negotiations, South Africa is moving to cut the cost of medicines with policies to increase imports and local production of generic drugs.
Patent? What patent? (Pharmacy in Asmara, Eritrea)
There is a window of opportunity for the least developed countries to develop their own pharmaceuticals industry.
If the proposals are agreed, they could delay the market entry of generic medicines in the region – and the impact will be felt around the world.
Seven rounds of negotiations for the Regional Comprehensive Economic Partnership have already taken place with virtually no public debate. The next round of negotiations begins today in Kyoto, Japan.
Pharmaceutical companies view the growing middle class in India and other emerging economies as a significant source of revenue.
India is the global focal point for legal and political struggles over patent rights and access to medicines. Particular attention is focused on the Swiss pharmaceutical giant Novartis, which is in battle…
Drug prices reduce dramatically when large multinationals’ monopoly is broken.
Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…
A Greens/EFA MEPs protest against ACTA at the European Parliament in Strasbourg. The protestors urged their fellow members to join them in standing up for democracy and a free internet.
©Photo European Union
The Anti-Counterfeiting Trade Agreement (ACTA) 2011 - Twitter hashtag #ACTA - is a controversial trade agreement designed to provide for stronger enforcement of intellectual property rights. There’s been…